Atomoxetine is the first non-stimulant drug approved for the treatment of attention-deficit hyperactivity disorder (ADHD). It is sold in the form of the hydrochloride salt of atomoxetine. Atomoxetine is a selective norepinephrine re-uptake inhibitor. It appears to work by blocking or slowing the reabsorption of norepinephrine...
Strattera (atomoxetine hcl) is approved for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children aged 6 and older, teens, and adults. Strattera should be used as part of a total treatment program for ADHD that may include counseling or other therapies...
Family history is a greater risk factor than lifestyle for developing some cancers, according to a Swedish study looking at 71,000 adopted people.
Despite an expansion in health care provision, a new study has found that the growth of health care expenditure in the US has slowed down over the past decade.
Scientists are mystified by the mechanism that 'reactivates' dormant viruses such as herpes. Now, a new study suggests interactions with other infections may be responsible.